-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Acer Therapeutics Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2022.
- Acer Therapeutics Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2023 was $233K, a 49.5% decline year-over-year.
- Acer Therapeutics Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2023 was $1.22M, a 36.5% decline year-over-year.
- Acer Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.84M, a 19.5% decline from 2021.
- Acer Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.29M, a 2.83% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)